Critical Care

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michelle Hughes, MD

Over the past two decades, there has been an increasing need for GI hospitalists to help provide rapid access to care. Since then, GI hospitalists have become an important part to many healthcare systems and their approach to patient care. Joining Dr. Peter Buch to discuss the benefits and challenges that come along with the GI hospitalist role is Dr. Michelle Hughes, Assistant Professor of Medicine and Medical Chief of Quality and Safety for Digestive Health at Yale New Haven Health.

Host: Megan Conroy, MD, MA(Ed)
Guest: Farrukh Abbas, MD

On average, more than two-thirds of patients with chronic obstructive pulmonary disease (COPD) make at least one error in using an inhaler device. Fortunately, nebulized long-acting muscarinic antagonists (LAMAs) can help our patients overcome this common challenge in COPD care. That’s why Drs. Megan Conroy and Farrukh Abbas come together to talk about the GOLD treatment guidelines, strategies for reducing patient hesitancy regarding nebulized LAMAs, and more.

This episode is produced in partnership with the American College of CHEST Physicians and is sponsored by Viatris Inc.

Host: Tom Corbridge, MD, FCCP
Guest: Michael E. Wechsler, MD, MMSc

Severe asthma is an uncontrolled disease that can be difficult to diagnose. To help us overcome this obstacle, Dr. Tom Corbridge joins Dr. Michael Wechsler from National Jewish Health in Denver to discuss the challenges we face while trying to diagnose severe asthma.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily Carroll, JD, MSW

The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.

Guest: Maureen Brogan, MD

The COVID-19 pandemic has impacted care across all specialties, and the 2021 American Society of Nephrology (ASN) Annual Meeting offered a platform for nephrologists to share their experiences. Tune in to hear how Dr. Maureen Brogan adapted her practice to overcome supply and staffing shortages.

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Hassan Bencheqroun, MD

Evaluating the need for therapy escalation can be challenging. So joining Dr. Charles Turck to help us understand how to escalate treatment for patients with chronic obstructive pulmonary disease is Dr. Hassan Bencheqroun, Assistant Professor of Medicine at the University of California Riverside School of Medicine.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Deborah Levine, MD, FCCP

To better understand whether or not corticosteroids should be incorporated in treatment for our patients with COPD, Dr. Charles Turck is joined by Dr. Deborah Jo Levine, a Professor of Medicine and Director of the Pulmonary Hypertension Center at the University of Texas Health.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Mario R. Nacinovich, Jr., MSc
Guest: Randy Young, MD

Amid the surge of the Delta variant, critical care physician Dr. Randy Young is traveling to ICUs across the country to help treat patients. Tune in to hear Dr. Young share how this surge is impacting both patients infected with the variant and the healthcare professionals caring for them.

Guest: Madhukar H. Trivedi, MD
Guest: Steven Shoptaw, PhD

Join Drs. Madhukar Trivedi and Steven Shoptaw as they discuss the evolving landscape of pharmacologic intervention for methamphetamine use disorder. Their focus will be on evidence from the ADAPT-2 clinical trial supporting the combination of extended release naltrexone and high dose bupropion to reduce methamphetamine use for patients with moderate to severe methamphetamine addiction. These important data from ADAPT-2 offer a significant therapeutic advance for methamphetamine use disorder that can be taken into the clinic.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Guest: Yvonne Michael, ScD, SM

Dr. Yvonne Michael, an Associate Professor at the Dornsife School of Public Health at Drexel University, discusses risk factors that we should take into consideration when examining postmenopausal patients with coronary heart disease.

Host: Michael Greenberg, MD
Guest: Sam Polesie, PhD

Can technology play a role in assessing melanoma? Dr. Michael Greenberg discusses the use of artificial intelligence in dermatology with Dr. Sam Polesie, a specialist physician in the Department of Dermatology and Venereology at the Sahlgrenska University Hospital in Gothenburg, Sweden.

Guest: Yvonne Michael, ScD, SM

Dr. Yvonne Michael, an Associate Professor at the Dornsife School of Public Health at Drexel University, shares her findings and discusses preventative measures we can share with postmenopausal patients to help them combat risk factors for coronary heart disease.

Host: Andrew Wilner, MD, FACP, FAAN
Guest: Maheen Mausoof Adamson, PhD

Traumatic brain injury, or TBI, manifests differently in men and women. Here to explore these differences is Dr. Maheen Mausoof Adamson, a Clinical Associate Professor of Neurosurgery at Stanford School of Medicine, meets with Dr. Andrew Wilner to discuss traumatic brain injuries in female patients.

Host: Jacob Sands, MD
Guest: Millie Das, MD

What are some of the latest advancements in small cell lung cancer? Dr. Jacob Sands discusses small-cell lung cancer treatment developments with Dr. Millie Das, a Clinical Associate Professor of Medical Oncology at Stanford University and Chief of Oncology at the Veteran’s Affairs Palo Alto Healthcare System.

Host: John Russell, MD
Guest: Paul Farmer, MD, PhD

Dr. John Russell meets with Dr. Paul Farmer, the Chair of Global Health at Harvard Medical School and co-founder of Partners in Health, to review past pandemics and outbreaks while discussing things we can do as a community to lower the risk of these events.

Host: Matthew P. Bars, MS, CTTS, NCTTP
Guest: Michael C. Fiore, MD, MPH, MBA
Guest: Laura E. Crotty Alexander, MD

Dr. Matt Bars is joined by his two colleagues: Dr. Laura Crotty Alexander, Associate Professor of Pulmonary Critical Care Medicine at the University of California San Diego, and Dr. Michael Fiore, Professor of Medicine at the University of Wisconsin and Director of the University of Wisconsin Center for Tobacco Research Intervention. Together, they review tobacco dependence, the CHEST Tobacco Dependence Treatment Toolkit, and resources to help patients.

Supported in part by an independent medical educational grant from Pfizer.

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Ana C Zamora Martinez, MD

The COVID-19 pandemic led many clinicians to make life-altering decisions. Dr. Ana Zamora, a pulmonary disease and critical care specialist, discusses her work with Locum Tenens and why she decided it was time for a change.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Cynthia L Sears, M.D.

Decreased resistance to antibiotics has adversely impacted our ability to fight H. pylori. How can we help our patients overcome this threat? Dr. Peter Buch is here today to discuss this issue with Dr. Cynthia Sears, professor of medicine at the Johns Hopkins University School of Medicine to help improve health outcomes for our patients.

Host: David Weisman, MD
Guest: Adil Javed, MD PhD

How can providers help mitigate the symptoms of a disease as debilitating as multiple sclerosis? Dr. David Weisman examines management strategies for patients with multiple sclerosis with is Dr. Adil Javed, a board-certified neurologist and an Associate Professor of Neurology at the University of Chicago.

Host: Matthew J. Sorrentino, MD, FACC, FASH
Guest: Eliot Brinton, MD, FAHA, FNLA

One of the leading causes of death in the US, cardiovascular disease risk-reduction has neglected triglycerides. To explain why that is, Dr. Matthew Sorrentino discusses approaches to take when reducing the risk of cardiovascular disease with expert guest, Dr. Elliot Brinton, president of the Utah Lipid Center in Salt Lake City.